Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Praful R. Nair has a total of 81 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Reprogramming CAR-T cell function through synthetic cytokine receptors suppresses metastatic progression of TNBC

    by Eban A. Hanna, Alice Amitrano, Andre Forjaz, Zhiliang Bai, Chanhong Min, Yoseph Dance, Immanuel Etoh, Bryce Lloyd, Xinyun Jiang, Vasco Queiroga, et al.

    Patient T cells modified with chimeric antigen receptors (CARs) have shown remarkable therapeutic success in previously incurable cancers. However, despite its success in hematological malignancies, CAR-T therapy has shown only modest efficacy in solid tumors. The medical field has focused on developing new molecular designs that enhance CAR-T persistence, prevent exhaustion in the tumor microenvironment (TME), and increase the specificity of the CAR-T cell to various tumor antigens. However, much less effort has been placed on enhancing CAR-T cells’ invasion into and migration through the stromal matrix of the TME, where they can elicit tumor-directed cytotoxicity. Here, we engineered CAR-T cells with synthetic cytokine receptors targeting inflammatory cytokines produced by the cells themselves, which increase their speed through collagen I matrices. We show that this enhanced motility is driven by increased CAR-T cell translocation through confined microchannels via cellular deformation, together with elevated migratory speeds in proximity to neighboring cells, suggesting improved responsiveness to local cues. These migration-enhanced CAR-T cells significantly reduce both primary tumor size and distant organ metastasis in triple-negative breast cancer (TNBC) mouse models compared to standard CAR-T cells. These results support molecular design strategies that exploit mechanisms to improve cellular therapies for metastatic solid tumors.

  • Open Access

    Hyper-migratory CAR T cells alleviate ovarian cancer metastatic burden and improve prognosis

    by Praful R. Nair, Eban Hanna, Saurabh Joshi, Victoria Duarte-Alvarado, Challice L. Bonifant, Denis Wirtz

    Cellular immunotherapy has shown remarkable efficacy in hematological malignancies but remains limited by infiltration issues in solid tumors, leading to poor treatment efficacy. We have recently shown that mesothelin-targeting CAR T cells co-transduced with cytokine-binding synthetic velocity receptors (VRs, referred to as CAR TV cells) demonstrate increased motility, improved infiltration in solid primary tumors, and lead to a better anti-tumor effect compared to CAR T cells that do not express VRs. However, it is metastasis that causes the vast majority of cancer related deaths and is difficult to target clinically, indicating an urgent unmet need. We show that these CAR T cells engineered to be hyper-migratory using VRs are highly effective against liver metastasis of ovarian cancer along different stages of the metastatic cascade. Mesothelin-targeting CAR TV cells expressing synthetic or native receptors responsive to the cytokine Interleukin-5 improved the survival of mice bearing an extremely high or ‘terminal’ level of metastatic burden compared to CAR T cells that did not express VRs. Against newly established metastatic lesions and lesions undergoing metastatic outgrowth, CAR TV cells showed a robust anti-cancer effect resulting in an improved prognosis compared to control CAR T cells. Histopathological assessments showed a substantial reduction of metastasis number and lesion size with CAR TV treatment, concomitant with increased immune cell infiltration in the metastatic regions. Our work demonstrates the efficacy of high-motility CAR T cells in a metastatic setting and extends their scope to the treatment of metastasis of solid tumors.

  • Open Access

    3D map-guided modeling of functional endometrial tissue using multi-compartment assembloids

    by Kehan A. Ren, Victoria Duarte-Alvarado, Xin Di Zhou, Bryan Ho, André Forjaz, Ashleigh J. Crawford, Gretchen M. Alicea-Rebecca, Saurabh Joshi, Praful Nair, Eban A Hanna, et al.

    The human endometrium is a dynamic tissue that lines the uterus and undergoes constant remodeling, making it especially susceptible to gynecological diseases like endometriosis and endometrial cancer. The molecular mechanisms of these conditions are not well understood, partly due to the lack of in vitro models that mimic endometrial physiology, which limits options for targeted intervention and treatment of these diseases. Mouse models are also inadequate, as common laboratory strains do not naturally undergo a menstrual cycle comparable to that of humans. This study addresses this need by developing a 3D multi-compartment assembloid that mimics the architecture of endometrial tissue and recapitulates all three phases of the menstrual cycle (proliferative, secretory, and menstrual regression) within a single platform. The cellular and extracellular matrix (ECM) components in each compartment are carefully tuned based on a 3D spatial cellular map of endometrial tissue. The model contains endometrial epithelial cells enveloped in a basement membrane and endometrial stromal cells in a surrounding collagen-rich layer; this architecture allows realistic interactions between these cells and their respective ECMs. This assembloid successfully supports the controlled growth and organization of these cells, revealing reciprocal regulation of cell behavior and exhibiting compartment-specific hormonal responses, i.e., stromal decidualization. This platform enables the study of dynamic, phase-resolved, and compartment-specific paracrine signaling in human endometrial biology. By combining tissue-informed design, modular fabrication, and full-cycle hormonal responsiveness, this model sets a new benchmark for blastocyst implantation studies, organ modeling, and precision diagnostics in human reproductive health.


  • Open Access

    Figure S4 from Small Extracellular Vesicles Promote Stiffness-mediated Metastasis

    by Alexandra Sneider, Ying Liu, Bartholomew Starich, Wenxuan Du, Praful R. Nair, Carolyn Marar, Najwa Faqih, Gabrielle E. Ciotti, Joo Ho Kim, Sejal Krishnan, et al.

    Plastic EVs have different biodistribution compared to stiff and soft EVs.

  • Open Access

    Supplementary Methods from Small Extracellular Vesicles Promote Stiffness-mediated Metastasis

    by Alexandra Sneider, Ying Liu, Bartholomew Starich, Wenxuan Du, Praful R. Nair, Carolyn Marar, Najwa Faqih, Gabrielle E. Ciotti, Joo Ho Kim, Sejal Krishnan, et al.

  • Open Access

    FIGURE 3 from Small Extracellular Vesicles Promote Stiffness-mediated Metastasis

    by Alexandra Sneider, Ying Liu, Bartholomew Starich, Wenxuan Du, Praful R. Nair, Carolyn Marar, Najwa Faqih, Gabrielle E. Ciotti, Joo Ho Kim, Sejal Krishnan, et al.

    Stiff EVs show increased biodistribution and retention in vivo.A, Schematic of EV isolation and staining prior to tail-vein injection of 10 µg of EVs in nude mice. NIR imaging (B) and mean SNR (C) of MDA-MB-231 vesicle biodistribution in dorsal, left, ventral, and right sides (mean ± SEM). Signal intensity is in arbitrary units (a.u.). Three mice in 0.5 kPa condition, and four in 25 kPa condition; one-way ANOVA. NIR imaging (D) and mean SNR biodistribution (E) in the lungs, liver, spleen, kidneys, and bone/bone marrow (mean ± SEM). Signal intensity is in arbitrary units (a.u.). Three mice in MDA-MB-231 0.5 kPa condition and four in 25 kPa condition; one-way ANOVA. F, MDA-MB-231 EV binding assay to ECM proteins collagen type I, collagen type IV, and laminin (mean ± SEM). Three biological repeats for collagen type I and collagen type IV; five for laminin. Paired t test.

  • Open Access

    FIGURE 4 from Small Extracellular Vesicles Promote Stiffness-mediated Metastasis

    by Alexandra Sneider, Ying Liu, Bartholomew Starich, Wenxuan Du, Praful R. Nair, Carolyn Marar, Najwa Faqih, Gabrielle E. Ciotti, Joo Ho Kim, Sejal Krishnan, et al.

    Stiff EVs promote cancer cell migration and dissemination. A, Schematic of 2-day GFP+ zebrafish embryo model system used to test the ability of MDA-MB-231 EVs (red, filled triangles) to disperse MDA-MB-231 cancer cells (blue, open triangles). Scale bar, 100 µm. B, Full zebrafish body images of the embryos at time 0 and 24 hours postinjection of MDA-MB-231 cancer cells. Scale bar, 100 µm. Representative images. C, Enlarged images of disseminated MDA-MB-231 cells (white) and EVs (red). Scale bar, 100 µm. Representative images. D, Percentage of injected embryos with cancer cell dissemination to the head or the tail. Total number of fish per condition is 47 for PBS control, 63 for 25 kPa, and 78 for 0.5 kPa condition. Five biological repeats of EVs. One-way ANOVA.

  • Open Access

    Figure S1 from Small Extracellular Vesicles Promote Stiffness-mediated Metastasis

    by Alexandra Sneider, Ying Liu, Bartholomew Starich, Wenxuan Du, Praful R. Nair, Carolyn Marar, Najwa Faqih, Gabrielle E. Ciotti, Joo Ho Kim, Sejal Krishnan, et al.

    Stiffness measurements of primary patient tissues

  • Open Access

    Table S1 from Small Extracellular Vesicles Promote Stiffness-mediated Metastasis

    by Alexandra Sneider, Ying Liu, Bartholomew Starich, Wenxuan Du, Praful R. Nair, Carolyn Marar, Najwa Faqih, Gabrielle E. Ciotti, Joo Ho Kim, Sejal Krishnan, et al.

    Table S1 - Primers for qRT-PCR analysis

  • Open Access

    FIGURE 1 from Small Extracellular Vesicles Promote Stiffness-mediated Metastasis

    by Alexandra Sneider, Ying Liu, Bartholomew Starich, Wenxuan Du, Praful R. Nair, Carolyn Marar, Najwa Faqih, Gabrielle E. Ciotti, Joo Ho Kim, Sejal Krishnan, et al.

    Matrix stiffness impacts the quantity of EVs produced by patient tissue. A, Representative primary breast tumor tissue. Sample has been mechanically mapped using microindentation. Dark circles indicate measurements of the elastic modulus expressed in units of kPa. Crosses are nonmeasurable indentations. Dotted lines indicate where the tissue was sectioned into stiff (middle) and soft (right) regions for subsequent vesicle collection. B, Mean compression measurements (kPa, mean ± SEM) of patient tumor and adjacent normal tissues. Ten adjacent normal tissue samples and nine tumor tissue samples. Nonparametric t test. C, Vesicles released per gram of tissue in pathologist determined tumor adjacent or tumor tissue patient samples. Ten normal tissue samples and eight tumor tissue samples. D, Combined tumor-adjacent and tumor tissues samples separated by mean compression measurements (kPa, mean ± SEM). Fourteen samples < 10 kPa and four samples > 10 kPa. E, Tumor samples separated by mean microindentation measurements (kPa, mean ± SEM). Thirteen samples < 10 kPa and six samples > 10 kPa. Nonparametric t test.